Stay updated on Atogepant 60mg for Episodic Migraine: Safety Clinical Trial
Sign up to get notified when there's something new on the Atogepant 60mg for Episodic Migraine: Safety Clinical Trial page.

Latest updates to the Atogepant 60mg for Episodic Migraine: Safety Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedA notice was added about NIH’s transition from “Artificial Intelligence” to “Super Intelligence” terminology. The site revision marker changed from v3.7.1 to v3.7.2.SummaryDifference0.8%

- Check15 days agoChange DetectedThe site footer now identifies the ClinicalTrials.gov platform as revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check43 days agoChange DetectedThe study record history now includes a new revision entry (v3.7.0) replacing the previous revision (v3.6.6). This reflects an updated version of the record metadata in the page history.SummaryDifference0.1%

- Check57 days agoChange DetectedA new page revision label 'Revision: v3.6.6' was added to the study record history, and the previous label 'Revision: v3.6.5' was removed, indicating a version update of the page content.SummaryDifference0.1%

- Check71 days agoChange DetectedThe References section at the bottom of the Study Record's history view was removed. This eliminates the list of sources cited for the record history.SummaryDifference0.2%

- Check79 days agoChange DetectedA new revision entry (v3.6.5) was added to the study record history, updating the versioning trail. The previous entry (v3.6.4) was removed from the current change set, so the history now shows the latest version.SummaryDifference0.1%

Stay in the know with updates to Atogepant 60mg for Episodic Migraine: Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atogepant 60mg for Episodic Migraine: Safety Clinical Trial page.